Mitochondria sense with different kinetics the calcium entering into HeLa cells through calcium channels CALHM1 and mutated P86L-CALHM1

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 722-726

  Moreno Ortega, Ana J ^a,b   Ruiz Nuño, Ana ^a,b   García, Antonio G ^a,b,c   Cano Abad, María F ^a,b,c  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b INSTITUTO TEÓFILO HERNANDO   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Aequorin; Alzheimer; Calcium; CALHM1; Mitochondria

Indexed keywords

CALCIUM; CALCIUM CHANNEL; CALCIUM HOMEOSTASIS MODULATOR 1; HISTAMINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL TYPE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FEMALE; GENE; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; KINETICS; MITOCHONDRION; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; APOPTOSIS; CALCIUM; CALCIUM CHANNELS; ENDOPLASMIC RETICULUM; HELA CELLS; HUMANS; KINETICS; LEUCINE; MEMBRANE GLYCOPROTEINS; MITOCHONDRIA; MUTATION; PROLINE;

EID: 72949085313     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.11.127     Document Type: Article

References (28)

1. Green K.N., and LaFerla F.M. Linking calcium to Abeta and Alzheimer's disease. Neuron 59 (2008) 190-194
2. Cano-Abad M.F., Villarroya M., Garcia A.G., Gabilan N.H., and Lopez M.G. Calcium entry through L-type calcium channels causes mitochondrial disruption and chromaffin cell death. J. Biol. Chem. 276 (2001) 39695-39704 10.1074/jbc.M102334200
3. 2+ determine nerve growth factor dependence of sympathetic ganglion cells. Proc. Natl. Acad. Sci. USA 86 (1989) 6421-6425
4. Franklin J.L., and Johnson Jr. E.M. Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium. Trends Neurosci. 15 (1992) 501-508
5. Bezprozvanny I., and Mattson M.P. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci. 31 (2008) 454-463
6. Hayley M., Perspicace S., Schulthess T., and Seelig J. Calcium enhances the proteolytic activity of BACE1: an in vitro biophysical and biochemical characterization of the BACE1-calcium interaction. Biochimica et Biophysica Acta (BBA) - Biomembranes 1788 (2009) 1933-1938
7. Diaz J.C., Simakova O., Jacobson K.A., Arispe N., and Pollard H.B. Small molecule blockers of the Alzheimer Aβ calcium channel potently protect neurons from Aβ cytotoxicity. Proc. Natl. Acad. Sci. USA 106 (2009) 3348-3353
8. Guo Q., Furukawa K., Sopher B.L., Pham D.G., Xie J., Robinson N., Martin G.M., and Mattson M.P. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport 8 (1996) 379-383
9. 2+ overload underlies Abeta oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs. PLoS ONE 3 (2008) e2718
10. Wood-Kaczmar A., Gandhi S., Yao Z., Abramov A.S.Y., Miljan E.A., Keen G., Stanyer L., Hargreaves I., Klupsch K., Deas E., Downward J., Mansfield L., Jat P., Taylor J., Heales S., Duchen M.R., Latchman D., Tabrizi S.J., and Wood N.W. PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS ONE 3 (2008) e2455
11. Gandhi S., Wood-Kaczmar A., Yao Z., Plun-Favreau H., Deas E., Klupsch K., Downward J., Latchman D.S., Tabrizi S.J., Wood N.W., Duchen M.R., and Abramov A.Y. PINK1-associated parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol. Cell 33 (2009) 627-638
12. Reddy P.H. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp. Neurol. 218 (2009) 286-292
13. 2+ exchanger. Cell Calcium 28 (2000) 317-327
14. 2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell 133 (2008) 1149-1161
15. P.J. Cui, L. Zheng, L. Cao, Y. Wang, Y.L. Deng, G. Wang, W. Xu, H.D. Tang, J.F. Ma, T. Zhang, J.Q. Ding, Q. Cheng, S.D. Chen, CALHM1 P86L polymorphism is a risk factor for Alzheimer's disease in the chinese population, J. Alzheimers Dis. (2009).
16. Bertram L., Schjeide B.M., Hooli B., Mullin K., Hiltunen M., Soininen H., Ingelsson M., Lannfelt L., Blacker D., and Tanzi R.E. No association between CALHM1 and Alzheimer's disease risk. Cell 135 (2008) 993-994 (author reply 994-996)
17. Urszula W., Elzbieta S., and Jacek K. Calcium ions in neuronal degeneration. IUBMB Life 60 (2008) 575-590
18. Marambaud P., Dreses-Werringloer U., and Vingtdeux V. Calcium signaling in neurodegeneration. Mol. Neurodegenerat. 4 (2009) 20
19. 2+ channels in PC12 cells. Cell Calcium 44 (2008) 339-352
20. c). A critical evaluation. J. Biol. Chem. 270 (1995) 9896-9903
21. 2+ revealed by specifically targeted recombinant aequorin. Nature 358 (1992) 325-327
22. Parekh A.B., and Penner R. Store depletion and calcium influx. Physiol. Rev. 77 (1997) 901-930
23. Demaurex N., Poburko D., and Frieden M. Regulation of plasma membrane calcium fluxes by mitochondria. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1787 (2009) 1383-1394
24. Duchen M.R. Mitochondria and calcium: from cell signalling to cell death. J. Physiol. (Lond) 529 (2000) 57-68
25. Demaurex N., and Poburko D. A revolving door for calcium. Science 326 (2009) 57-58
26. 2+ transients that modulate secretion. Nat. Cell Biol. 2 (2000) 57-61
27. 2+ release in chromaffin cells seen from inside the ER with targeted aequorin. J. Cell Biol. 144 (1999) 241-254 10.1083/jcb.144.2.241
28. 2+ transfer from the ER to mitochondria: When, how and why. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1787 (2009) 1342-1351